-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Biotechnology Industry
Docs at BIO: Steve Burrill’s State of the Biotechnology Industry Report 2011
Kevin Noonan from patent Patent Docs writes: The underlying theme of his message this year was that the predominant feature of the biotechnology environment is change, and rapid change. Such change provides challenges but in characteristic fashion Mr. Burrill … espoused the belief that change provides “extraordinary opportunities.” Patent Docs is part of our BIO Official Blogger Program.
Five things you need to know about the state of the industry
What is the state of the biotechnology industry? To find out where the it stands and what strategies you need to survive, read Ernst & Young’s 25th annual industry report, Beyond borders: global biotechnology report 2011, that was released during a super session at the 2011 BIO International Convention. What were the industry’s profits last year? What kind of companies received funding? How should you engage the regulators? What new competencies do you need to Read More >
Evolution of Biotech Industry is a Constant
Healthcare being delivered by smartphone, homes containing treatment capabilities now only found in hospitals, groundbreaking innovations rising from the confluence of technology and science. Change is constant in the biotech industry and few industry experts know its evolution better than Steven Burrill. Burrill, CEO of Burrill and Company, presented his 25th anniversary annual report on the state of the biotech industry Biotech 2011-Life Sciences: Looking Back to See Ahead at the 2011 BIO International Convention Read More >
Five international biotech countries to watch
Scientific American released their third annual WorldView: A Global Biotechnology Perspective at the 2011 BIO International Convention which includes a Bio Innovation Scorecard. The Scorecard reviews individual country biotechnology programs and policies aimed at growing local innovative biotechnology sectors. Based on the results of the Bio Innovation Scorecard, here’s our list of 5 biotechs to watch: 5. Malaysia: Ranking third in the world for the best Enterprise Support of its biotech industry by Scientific American’s Read More >
Innovative China: Policies for the Future
As the second largest and fastest growing market for biotechnology products, China needs no introduction. The opportunity to heal, fuel, and feed 1.3 billion global citizens stands in clear contrast with the regulatory, financial, and political frameworks that present challenges to the life science industry’s external access to the evolving Chinese market. On Tuesday at the 2011 BIO International Convention, a panel discussion titled “Innovative China: Policies for the Future” addressed the future of the Read More >
